Clinical Trials Directory

Trials / Completed

CompletedNCT03295071

REALITY LHON Registry

Observational Registry Study of Leber Hereditary Optic Neuropathy (LHON) Affected Patients

Status
Completed
Phase
Study type
Observational
Enrollment
44 (actual)
Sponsor
GenSight Biologics · Industry
Sex
All
Age
Healthy volunteers
Not accepted

Summary

This study is a multi-country retrospective and cross-sectional observational study of affected LHON subjects, based on retrospective subjects' medical chart abstractions and cross-sectional administration of patient-reported outcomes (PROs).

Detailed description

The purpose of this study is to understand the evolution of visual functional and structural changes and other associated symptoms in patients with LHON. The relation between genetic, lifestyle and/or environmental factors and the LHON disease will be described, and a better understanding of the natural history of LHON disease and the healthcare associated to with the disease will be sought. In addition, we would also like to understand the economic burden for patients and their families with LHON resulting from direct and indirect costs they may have because of their disease.

Conditions

Interventions

TypeNameDescription
OTHERPatient-reported outcomes (PROs)Patient-reported outcomes (PROs)

Timeline

Start date
2018-01-03
Primary completion
2020-07-01
Completion
2020-07-01
First posted
2017-09-27
Last updated
2026-03-02

Locations

11 sites across 5 countries: United States, France, Italy, Spain, United Kingdom

Source: ClinicalTrials.gov record NCT03295071. Inclusion in this directory is not an endorsement.